A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1997
12/09/1997	US5696108 Protein kinase C inhibitors
12/09/1997	US5696076 5-lipoxygenase-activating protein II
12/09/1997	US5695760 Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
12/09/1997	US5695753 Transglutaminases as immunosuppressants
12/09/1997	US5695752 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
12/09/1997	CA2127115C Methane diphosphonic acid derivative, its production process and its pharmaceutical applications
12/09/1997	CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
12/04/1997	WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
12/04/1997	WO1997045437A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	WO1997045428A1 Novel pyridazine compounds
12/04/1997	WO1997045425A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
12/04/1997	WO1997045407A1 Novel anandamide amidase inhibitors as analgesic agents
12/04/1997	WO1997045402A1 Phenylsulfonamide derivatives
12/04/1997	WO1997045400A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
12/04/1997	WO1997045397A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
12/04/1997	WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis
12/04/1997	WO1997045111A1 Phenyl derivatives useful as blockers of chloride channels
12/04/1997	CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/04/1997	CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	CA2256358A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	CA2252747A1 Novel pyridazine compounds
12/03/1997	EP0810218A1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II)
12/03/1997	EP0809699A1 New chemokines expressed in pancreas
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809635A1 Alpha-substituted hydrazides having calpain inhibitory activity
12/03/1997	EP0809630A1 Indole derivatives with affinity for the cannabinoid receptor
12/03/1997	EP0809622A1 Anti-inflammatory benzoic acid derivatives
12/03/1997	EP0809511A1 Inhibition of angiogenesis using interleukin-12
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0809492A1 Il-8 receptor antagonists
12/03/1997	EP0809490A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
12/03/1997	EP0660825B1 Anti-inflammatory macrolactam (cyclamenol)
12/03/1997	CN1166834A Benzopyram and benzo-fused compounds, their preparation and their use as leukotriene B4'(LTB4) antagonists
12/03/1997	CN1166825A Metalloproteinase inhibitors
12/03/1997	CN1166785A Pharmaceutical control of inflammation
12/03/1997	CN1036591C Carbamates of repamycin
12/02/1997	US5693857 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
12/02/1997	US5693844 2-cyano-3-hydroxy-propenamides
12/02/1997	US5693818 Process for preparing pure salts of pyridinylmethyl-sulfinyl-1H-benzimidazole
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693676 Using nitroglycerin to treat anal fissures or ulcers, hemorrhoids, levator spasms
12/02/1997	US5693669 Dissolving tilidine in mixture of isopropanol and water, mild heating and stirring while adding phosphoric acid, then cooling and crystallization yields stable tilidine dihydrogen orthophosphate
12/02/1997	US5693649 N-substituted azaheterocyclic carboxylic acids and esters thereof
12/02/1997	US5693627 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/02/1997	US5693621 Inhibiting binding of selectin to carbohydrate ligands
12/02/1997	US5693607 Administering to treat fibroproliferative disorders
12/02/1997	CA2050639C Arylalkylamines, process for preparing them and pharmaceutical compositions containing them
11/1997
11/27/1997	WO1997044337A1 Benzofuran carboxamides and their therapeutic use
11/27/1997	WO1997044329A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/27/1997	WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	WO1997044051A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
11/27/1997	WO1997044045A1 Malatonin in combination with analgesics
11/27/1997	WO1997044044A1 Therapeutic uses for an aminosterol compound
11/27/1997	WO1997044031A1 Agent for treating allergic dermatitis
11/27/1997	WO1997044028A1 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
11/27/1997	WO1997044022A1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
11/27/1997	CA2255838A1 Melatonin in combination with analgesics
11/27/1997	CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	CA2252537A1 Benzofuran carboxamides and their therapeutic use
11/26/1997	EP0808365A1 Human interleukin-1 receptor accessory protein
11/26/1997	EP0808327A1 Proline derivatives useful as inhibitors of human leukocyte elastase
11/26/1997	EP0808156A1 Compositions comprising nanoparticles of nsaid
11/26/1997	EP0643712B1 Spiro-oxetanes, process for preparing the same and medicaments
11/26/1997	CN1166167A Novel prostaglandin synthase inhibitors
11/26/1997	CN1165817A New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
11/25/1997	US5691382 Enzyme inhibitors for cardiovascular disorders
11/25/1997	US5691381 Antagonist of tumor necrosis factor, antiinflammatory agent, antiarthritic agent
11/25/1997	US5691374 Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
11/25/1997	US5691359 Antiinflammatory agents
11/25/1997	US5691343 Crohn*s disease
11/25/1997	US5691340 Benzopyran derivatives
11/25/1997	US5691336 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
11/25/1997	US5691311 Methods for coating invasive devices with inhibitors of thrombin
11/25/1997	US5690961 Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
11/25/1997	CA2132541C Quinuclidine derivatives as substance p antagonists
11/25/1997	CA1339558C Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
11/20/1997	WO1997043304A1 Novel compounds
11/20/1997	WO1997043303A1 Novel compounds
11/20/1997	WO1997043251A1 Compounds with anti-inflammatory and immunosuppressive activities
11/20/1997	WO1997043250A1 Hydroxamic acid based inhibitors of the formation of cd23 and tnf
11/20/1997	WO1997043249A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
11/20/1997	WO1997043247A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997042962A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/20/1997	WO1997042952A1 Percutaneous tape preparation containing fentanyl
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	DE19613976C1 Thalidomid-Prodrugs mit immunmodulatorischer Wirkung Thalidomide prodrugs with immunomodulatory effect
11/20/1997	CA2253590A1 Inhibitors of the production of s-cd23 and the secretion of tnf
11/20/1997	CA2226834A1 A tape formulation for percutaneous administration containing fentanyl
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0807437A1 Polyacrylilic and polymethacrylic acid containing compositions with antiadhesion properties
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807124A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy

1 ... 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 ... 1272